NYSE:LLY   Eli Lilly and Company
Healthcare has been a safe bet this past year and is starting to look weak across the board. The sector is usually defensive, but it feels overbought. Should see continued selling.

Short term PT: $320
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.